In particular, studies, including ours, have demonstrated the critical involvement of a widely expressed G-protein-coupled, platelet-activating factor receptor (PAFR) pathway in augmenting tumor growth, including in lung cancer, and impeding the efficacy of cancer therapies [18,19,20,21]. Here, PTAFR is linked to lung carcinoma.